Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group

This study was designed to measure improvement in quality of life of patients with asthma, using a standardized disease-specific questionnaire, the St George's Respiratory Questionnaire, in a year long double-blind, placebo-controlled, group comparative study with nedocromil sodium. Two other questionnaires were used: the Sickness Impact Profile (a measure of general health) and the Hospital Anxiety and Depression Scale. Measurements were made at baseline and following 24 and 48 weeks of treatment. Response to therapy was also evaluated using daily diary card and peak flow measurements, clinic assessments and spirometry. Following a 4 week baseline, 719 adult asthmatics were randomized to treatment with 4 mg nedocromil sodium or placebo. Patients currently maintained on inhaled corticosteroids received treatments four times daily, those on bronchodilator alone received treatments twice daily. The Impacts component of the St George's Respiratory Questionnaire was significantly improved in patients receiving nedocromil sodium, as were night-time asthma, asthma severity at clinic, and daytime inhaled bronchodilator use. In patients receiving placebo, most of the traditional variables improved, and all three questionnaires recorded significant improvements in health. Patients and clinicians judged nedocromil sodium more effective than placebo. The improvement in St George's Questionnaire score in the nedocromil sodium treated patients was approximately double the change considered to be clinically significant. The study has shown that improvements in health with prophylactic therapy for asthma may be quantified by the use of a standardized disease-specific questionnaire.

This article has been cited by other articles:

				E. A Holloway and R. J West Integrated breathing and relaxation training (the Papworth method) for adults with asthma in primary care: a randomised controlled trial Thorax, December 1, 2007; 62(12): 1039 - 1042. [Abstract] [Full Text] [PDF]

				A. Ernst, A. Majid, D. Feller-Kopman, J. Guerrero, P. Boiselle, S. H. Loring, C. O'Donnell, M. DeCamp, F. J. F. Herth, S. Gangadharan, et al. Airway Stabilization With Silicone Stents for Treating Adult Tracheobronchomalacia: A Prospective Observational Study Chest, August 1, 2007; 132(2): 609 - 616. [Abstract] [Full Text] [PDF]

				Endpoints in asthma drug trials - what do they mean? DTB, March 1, 2006; 44(3): 21 - 24. [Abstract] [Full Text] [PDF]

				J. Bourbeau, M. Julien, F. Maltais, M. Rouleau, A. Beaupre, R. Begin, P. Renzi, D. Nault, E. Borycki, K. Schwartzman, et al. Reduction of Hospital Utilization in Patients With Chronic Obstructive Pulmonary Disease: A Disease-Specific Self-management Intervention Arch Intern Med, March 10, 2003; 163(5): 585 - 591. [Abstract] [Full Text] [PDF]

				P.W. Jones Interpreting thresholds for a clinically significant change in health status in asthma and COPD Eur. Respir. J., March 1, 2002; 19(3): 398 - 404. [Abstract] [Full Text] [PDF]

				B. Stenius-Aarniala, T. Poussa, J. Kvarnström, E.-L. Grönlund, M. Ylikahri, and P. Mustajoki Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study BMJ, March 25, 2000; 320(7238): 827 - 832. [Abstract] [Full Text]

				L. M. OSMAN, C. CALDER, R. ROBERTSON, J. A. R. FRIEND, J. S. LEGGE, and J. GRAHAM DOUGLAS Symptoms, Quality of Life, and Health Service Contact among Young Adults with Mild Asthma Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 498 - 503. [Abstract] [Full Text]

				F. GALLEFOSS, P. S. BAKKE, and P. KJAERSGAARD Quality of Life Assessment after Patient Education in a Randomized Controlled Study on Asthma and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 812 - 817. [Abstract] [Full Text]

				T. A. Davidson, E. S. Caldwell, J. R. Curtis, L. D. Hudson, and K. P. Steinberg Reduced Quality of Life in Survivors of Acute Respiratory Distress Syndrome Compared With Critically Ill Control Patients JAMA, January 27, 1999; 281(4): 354 - 360. [Abstract] [Full Text] [PDF]

				J. RANDALL CURTIS, G. D. RUBENFELD, and L. D. HUDSON Training Pulmonary and Critical Care Physicians in Outcomes Research . Should We Take the Challenge? Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1012 - 1015. [Full Text] [PDF]

				P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]

				J. R. CURTIS, D. P. MARTIN, and T. R. MARTIN Patient-assessed Health Outcomes in Chronic Lung Disease . What are They, How Do They Help Us, and Where Do We Go From Here? Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): 1032 - 1039. [Full Text] [PDF]

				C. B. WILSON, P. W. JONES, C. J. O'LEARY, P. J. COLE, and R. WILSON Validation of the St. George's Respiratory Questionnaire in Bronchiectasis Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 536 - 541. [Abstract] [Full Text]